News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
104,494 Results
Type
Article (4435)
Company Profile (24)
Press Release (100035)
Multimedia
Podcasts (6)
Webinars (1)
Section
Business (40611)
Career Advice (109)
Deals (6997)
Drug Delivery (18)
Drug Development (13207)
Employer Resources (15)
FDA (2478)
Job Trends (3307)
News (61531)
Policy (4248)
Tag
Academia (351)
Allergies (22)
Alliances (4645)
ALS (22)
Alzheimer's disease (216)
Antibody-drug conjugate (ADC) (16)
Approvals (2519)
Artificial intelligence (28)
Autoimmune disease (4)
Automation (4)
Bankruptcy (52)
Best Places to Work (2905)
BIOSECURE Act (2)
Biosimilars (19)
Biotechnology (17)
Bladder cancer (22)
Brain cancer (6)
Breast cancer (67)
Cancer (478)
Cardiovascular disease (39)
Career advice (96)
Career pathing (2)
CAR-T (18)
Cell therapy (69)
Cervical cancer (3)
Clinical research (11457)
Collaboration (119)
Company closure (1)
Compensation (48)
COVID-19 (372)
CRISPR (11)
C-suite (24)
Cystic fibrosis (11)
Data (570)
Depression (7)
Diabetes (47)
Diagnostics (1056)
Digital health (4)
Diversity, equity & inclusion (2)
Drug discovery (20)
Drug pricing (17)
Duchenne muscular dystrophy (16)
Earnings (31504)
Editorial (7)
Employer branding (3)
Employer resources (13)
Events (13591)
Executive appointments (76)
FDA (2826)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (91)
Gene editing (27)
Generative AI (3)
Gene therapy (44)
GLP-1 (109)
Government (651)
Grass and pollen (2)
Guidances (118)
Healthcare (3332)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (18)
Indications (2)
Infectious disease (395)
Inflammatory bowel disease (30)
Inflation Reduction Act (2)
Influenza (7)
Intellectual property (9)
Interviews (13)
IPO (4465)
IRA (8)
Job creations (542)
Job search strategy (86)
Kidney cancer (1)
Labor market (11)
Layoffs (98)
Legal (674)
Liver cancer (14)
Lung cancer (72)
Lymphoma (38)
Machine learning (2)
Management (5)
Manufacturing (41)
MASH (20)
Medical device (2470)
Medtech (2472)
Mergers & acquisitions (2607)
Metabolic disorders (120)
Multiple sclerosis (21)
NASH (4)
Neurodegenerative disease (14)
Neuropsychiatric disorders (4)
Neuroscience (321)
NextGen: Class of 2025 (897)
Non-profit (509)
Now hiring (2)
Obesity (56)
Opinion (22)
Ovarian cancer (14)
Pain (11)
Pancreatic cancer (12)
Parkinson's disease (20)
Partnered (3)
Patents (17)
Patient recruitment (15)
Peanut (12)
People (4675)
Pharmaceutical (4)
Pharmacy benefit managers (5)
Phase I (2692)
Phase II (4825)
Phase III (4803)
Pipeline (679)
Policy (30)
Postmarket research (473)
Preclinical (859)
Press Release (5)
Prostate cancer (24)
Psychedelics (5)
Radiopharmaceuticals (41)
Rare diseases (64)
Real estate (693)
Recruiting (7)
Regulatory (3277)
Reports (10)
Research institute (281)
Resumes & cover letters (15)
Rett syndrome (1)
RNA editing (2)
RSV (10)
Schizophrenia (26)
Series A (15)
Series B (5)
Service/supplier (1)
Sickle cell disease (12)
Special edition (5)
Spinal muscular atrophy (32)
Sponsored (6)
Startups (369)
Stomach cancer (2)
Supply chain (4)
Tariffs (11)
The Weekly (6)
Vaccines (119)
Venture capitalists (4)
Weight loss (29)
Women's health (1)
Worklife (2)
Date
Today (43)
Last 7 days (328)
Last 30 days (731)
Last 365 days (6791)
2025 (2597)
2024 (7138)
2023 (8390)
2022 (9456)
2021 (10000)
2020 (8988)
2019 (7616)
2018 (5870)
2017 (5190)
2016 (4534)
2015 (5916)
2014 (3665)
2013 (2500)
2012 (2628)
2011 (3194)
2010 (3259)
Location
Africa (86)
Alabama (8)
Arizona (16)
Asia (5857)
Australia (749)
California (1376)
Canada (368)
China (84)
Colorado (53)
Connecticut (60)
Delaware (48)
Europe (15743)
Florida (143)
Georgia (48)
Idaho (10)
Illinois (100)
India (5)
Indiana (72)
Iowa (2)
Japan (62)
Kansas (12)
Kentucky (8)
Louisiana (5)
Maine (19)
Maryland (150)
Massachusetts (881)
Michigan (31)
Minnesota (66)
Mississippi (1)
Missouri (13)
Montana (4)
Nebraska (1)
Nevada (14)
New Hampshire (19)
New Jersey (484)
New York (445)
North Carolina (180)
North Dakota (1)
Northern California (652)
Ohio (23)
Oklahoma (2)
Oregon (5)
Pennsylvania (324)
Puerto Rico (1)
Rhode Island (4)
South America (141)
South Carolina (2)
Southern California (537)
Tennessee (14)
Texas (145)
United States (4897)
Utah (95)
Virginia (19)
Washington D.C. (10)
Washington State (118)
Wisconsin (7)
104,494 Results for "35".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
After multiple rounds of layoffs that cut Kronos down to just 10 people, the small molecule biotech has accepted a buyout offer from Kevin Tang’s Concentra Biosciences.
May 2, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
SafeHeal(R) Closes Oversubscribed €35 Million Series C Equity Financing
May 7, 2025
·
4 min read
FDA
Threat to FDA User Fees Program Could Set US Back 35 Years
Experts express concern that last week’s unprecedented FDA layoffs will trigger a little-known mechanism that could result in a “disaster” the Trump administration doesn’t see coming.
April 10, 2025
·
5 min read
·
Heather McKenzie
Press Releases
BioVersys to Present BV100 Phase 2 Data at 35th ESCMID Global 2025
April 8, 2025
·
10 min read
Press Releases
Wheeler Bio Announces Oversubscribed $35M Series, Plans for Expansion and Continued Growth
March 20, 2025
·
3 min read
Collaboration
AstraZeneca Sets Sights and $1.35B on Subcutaneous Cancer Drugs With Alteogen Alliance
Monday was a busy day for AstraZeneca, which also paid up to $1 billion to acquire Belgian biotech EsoBiotec and its cell therapy pipeline and technology.
March 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 14, 2025
·
1 min read
Press Releases
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 5, 2025
·
1 min read
Press Releases
BrainsWay to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 4, 2025
·
1 min read
Press Releases
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 3, 2025
·
1 min read
1 of 10,450
Next
